XML 71 R59.htm IDEA: XBRL DOCUMENT v3.25.2
Financial Instruments and Fair Value Measurements (Narrative) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 27, 2025
Jun. 28, 2024
Jun. 27, 2025
Jun. 28, 2024
Dec. 27, 2024
Mar. 13, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis            
Derivative, Notional Amount           $ 860.0
Derivative, Interest Rate Cap, Premium           $ 20.0
Derivative, Cap Interest Rate           3.84%
Equity Securities, FV-NI, Unrealized Gain (Loss) $ 4.0 $ (4.3) $ (2.2) $ 2.7    
Interest Rate Cap            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis            
Unrealized Gain (Loss) on Derivatives (0.4) (0.8) (3.0) 1.3    
Embedded Derivative Financial Instruments            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis            
Unrealized Gain (Loss) on Derivatives   (0.6)   5.3    
Recurring            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis            
Derivative Liability 0.0   0.0   $ 0.0  
Investments, Fair Value Disclosure 26.2   26.2   25.4  
Other Assets, Fair Value Disclosure 9.8   9.8   12.0  
Cash Flow Hedge Derivative Instrument Assets at Fair Value 2.3   2.3   5.3  
Assets, Fair Value Disclosure 38.3   38.3   42.7  
Deferred Compensation Liability, Fair Value 21.1   21.1   22.5  
Contingent consideration and acquired contingent liabilities 18.3   18.3   17.5  
Financial and Nonfinancial Liabilities, Fair Value Disclosure 39.4   39.4   40.0  
Level 3 | Other current and non-current assets            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis            
Cash surrender value of life insurance 44.9   44.9   43.7  
Level 3 | Recurring            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis            
Investments, Fair Value Disclosure 0.0   0.0   0.0  
Other Assets, Fair Value Disclosure 0.0   0.0   0.0  
Cash Flow Hedge Derivative Instrument Assets at Fair Value 0.0   0.0   0.0  
Assets, Fair Value Disclosure 0.0   0.0   0.0  
Deferred Compensation Liability, Fair Value 0.0   0.0   0.0  
Contingent consideration and acquired contingent liabilities 18.3   18.3   17.5  
Financial and Nonfinancial Liabilities, Fair Value Disclosure 18.3   18.3   17.5  
Level 3 | Recurring | Contingent Liabilities            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis            
Fair value adjustment 0.9 $ 0.7 0.8 $ 2.1    
Level 2 | Recurring            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis            
Investments, Fair Value Disclosure 8.9   8.9   8.0  
Other Assets, Fair Value Disclosure 0.0   0.0   0.0  
Cash Flow Hedge Derivative Instrument Assets at Fair Value 2.3   2.3   5.3  
Assets, Fair Value Disclosure 11.2   11.2   13.3  
Deferred Compensation Liability, Fair Value 21.1   21.1   22.5  
Contingent consideration and acquired contingent liabilities 0.0   0.0   0.0  
Financial and Nonfinancial Liabilities, Fair Value Disclosure 21.1   21.1   22.5  
Level 1 | Recurring            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis            
Investments, Fair Value Disclosure 17.3   17.3   17.4  
Other Assets, Fair Value Disclosure 9.8   9.8   12.0  
Cash Flow Hedge Derivative Instrument Assets at Fair Value 0.0   0.0   0.0  
Assets, Fair Value Disclosure 27.1   27.1   29.4  
Deferred Compensation Liability, Fair Value 0.0   0.0   0.0  
Contingent consideration and acquired contingent liabilities 0.0   0.0   0.0  
Financial and Nonfinancial Liabilities, Fair Value Disclosure 0.0   0.0   0.0  
Indemnification Agreement | Level 1            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis            
Restricted Cash and Cash Equivalents $ 61.2   $ 61.2   $ 63.1